Getting an NHP product licence in Canada is the single most important compliance step for any brand entering the natural health product market — and it's where most new brands lose months they can't afford. Health Canada's Natural and Non-prescription Health Products Directorate reviews every application individually, and the quality of your submission determines whether you wait 60 days or 18 months. If you're building a private label herbal line, understanding what Health Canada evaluates — and how your contract manufacturer fits into the picture — can cut your time-to-market significantly.
Key Takeaways
- Every natural health product sold in Canada requires a product licence (NPN or DIN-HM) — no exceptions
- Your contract manufacturer holds the site licence; you, as the brand owner, hold and own the product licence
- Most private label herbal tinctures qualify for the traditional use evidence pathway — faster and less costly
- Most application delays originate in pre-submission preparation, not Health Canada's review queue
- A GMP-certified contract manufacturer with Health Canada experience significantly reduces your compliance burden
NHP Product Licence: What It Is and Why Every Brand Needs One
An NHP product licence — issued as either a Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) — is required for every natural health product sold in Canada. Without it, Health Canada can order your product off shelves, seize inventory, and issue fines. There is no grace period for new brands entering the market.
The licence covers the product itself: its ingredients, dosage form, potency, recommended conditions of use, and the health claims on your label. It is product-specific — a 100 mL echinacea tincture and a 50 mL echinacea tincture require two separate NHP product licence applications in Canada, even when the formulation is identical. Size, form, and concentration are all licence variables.
Here's what that means in practice: if you're launching a line of ten herbal tinctures, you need ten product licences. Batching your submissions — preparing and submitting them as a coordinated set — is one of the most effective ways to manage that workload without multiplying your timeline by ten.
Site Licence vs Product Licence: Who Needs What
Brand owners frequently confuse these two requirements, and the confusion costs time. They cover different parts of the supply chain and are held by different parties.
A site licence is held by the manufacturer. It confirms the facility meets GMP standards and is authorized to produce NHP products. Your contract manufacturer holds this licence. As a brand owner working with a contract facility, you do not need a site licence — that's your manufacturer's obligation to maintain.
A product licence is held by you, the brand owner. You apply for it, you own the NPN, and you are responsible for the product's ongoing compliance with its approved conditions of use. The product licence travels with the brand, not the facility — if you ever change manufacturers, you keep your NPN.
The practical implication: when you work with a GMP-certified contract manufacturer, you're building on their site licence. Your compliance obligation is the product licence — the formulation, the claims, the label, and the evidence package that supports all of it.
NHP Evidence Requirements: Traditional Use vs Clinical Evidence
Health Canada evaluates NHP submissions under two evidence frameworks. Choosing the right one before you write your submission determines whether your application is straightforward or resource-intensive.
Traditional use evidence applies when your claims reference historical or traditional applications — for example, "traditionally used in herbal medicine to support digestive health." You'll need references from herbal pharmacopoeias or traditional medicine texts published at least 50 years ago, or documented use in a recognized herbal tradition. This pathway is accessible for most single-herb tinctures and standard formula categories. It is the default pathway for the majority of private label herbal products.
Modern evidence applies for structure/function or disease-specific claims. You'll need clinical studies or systematic reviews directly supporting the claim. This pathway is considerably more resource-intensive and is typically appropriate for well-researched ingredients with a strong clinical evidence base: berberine for blood glucose, valerian for sleep latency, melatonin for circadian support.
Worth understanding before you proceed: overstating your health claims is the fastest way to trigger a request for additional evidence — and a multi-month delay. If your formula doesn't have a clinical evidence base, traditional use framing is not a compromise. It's the correct pathway for that product.
Health Canada NHP Review Timelines: What to Plan For
Health Canada's published service standard is 60 days for a complete traditional use NHP application, and up to 300 days for modern evidence submissions. In practice, timelines vary based on submission quality, product category, and Health Canada's current review volumes.
This is where most brands run into trouble. The most common cause of delay isn't Health Canada's queue — it's incomplete or deficient submissions. Common deficiencies that trigger a Clarification Request (CR) include: insufficient evidence for the claimed benefit; inadequate product specifications or missing stability data; label non-compliance identified at review; missing or incorrect site licence details for the manufacturing facility.
When Health Canada issues a CR, your application clock resets. A single CR can add three to six months to your timeline. Two CRs can turn a 60-day process into a year-long one.
Before we submit anything on behalf of our clients, we review the submission package — specifications, label, evidence references — against Health Canada's current guidance. Pre-submission review is the single most effective way to compress your actual time-to-licence, and it's the step most brands skip when they're in a hurry to launch.
NHP Label Compliance: What Every Label Must Include
Your NHP product licence approves a specific label. If your label doesn't match what was approved — even a minor wording discrepancy — you're out of compliance, regardless of whether your formulation is correct. Health Canada's NHP labelling requirements are specific and enforced.
Every NHP label in Canada must include: the Natural Product Number (NPN) or DIN-HM displayed prominently on the principal display panel; the licensed product name exactly as approved; recommended use, dose, duration of use, and route of administration; all required risk information including cautions, warnings, and contraindications; medicinal ingredients listed with common name, proper name, quantity per dosage unit, and source material.
Also required: all non-medicinal ingredients in descending order of proportion; net quantity of product in the container; lot number and expiry date; and the name and address of the licence holder — you, the brand owner, not the manufacturer.
One requirement catches brands off guard: bilingual labelling. For national distribution in Canada, all required label elements must appear in both English and French. The short version: build your label to spec before you submit your NHP product licence application in Canada. Label deficiencies are the most common source of Clarification Requests, and they're the easiest ones to prevent.
How Contract Manufacturing Reduces Your NHP Licensing Burden
Working with a GMP-certified contract manufacturer doesn't just produce your product — it builds the compliance foundation your NHP product licence application requires.
We hold a Health Canada site licence for NHP manufacturing. Every batch we produce comes with a Certificate of Analysis confirming identity, potency, and purity — exactly the documentation your product licence submission needs. We maintain extraction ratios, menstruum specifications, and batch records in a format aligned with Health Canada's current expectations.
For brand owners building a private label herbal product line, this means you're not constructing your compliance framework from scratch. The manufacturing side — GMP-certified facility, active site licence, batch documentation — is handled. Your focus is the NHP product licence itself: your formulation, your health claims, your label.
Your manufacturer's QC program is part of the evidence picture too — see our breakdown of herbal extract quality testing in Canada to understand what rigorous testing looks like from a manufacturer's perspective.
Getting your NHP product licence in Canada takes preparation, not guesswork. Choosing the right evidence pathway, building your label to spec before submission, and working with a licensed manufacturing facility that understands what Health Canada reviewers look for — those are the factors that separate brands that clear first review from those that spend a year in back-and-forth.
Published: April 30, 2026